Logo

Invitrogen Expects to Complete Financing Next Week to Help Fund ABI Acquisition

Sep 17, 2008
NEW YORK (GenomeWeb News) – Invitrogen said yesterday that it expects to complete within the next seven days a $2.65 billion bank facility to partially fund its roughly $6.7 billion acquisition of Applied Biosystems.
 
Invitrogen said that the facility, which is being underwritten by Bank of America, UBS, and Morgan Stanley, is “substantially oversubscribed.”
 
The Carlsbad, Calif.-based firm also said that it is currently engaged with the European Commission regarding European approval of the deal. The acquisition cleared the US antitrust waiting period in late July.
 
Invitrogen and ABI sent out a joint proxy statement/prospectus regarding the acquisition to shareholders last week. The shareholders of both firms will vote on the deal next month, with closure of the transaction expected in the fourth quarter of this year.

Breaking News
The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.